Demetrios G. Karamanolis

Learn More
BACKGROUND-AIM The aim of this study is to identify the long term benefit of one year infliximab administration for the treatment of chronic refractory pouchitis following ileo-pouch anal anastomosis (IPAA) for ulcerative colitis (UC). METHODS Seven patients with chronic refractory pouchitis diagnosed by clinical, endoscopic and histological criteria(More)
  • 1